Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Deep microbial analysis of multiple placentas shows no evidence for a placental microbiome.

Kuperman AA, Zimmerman A, Hamadia S, Ziv O, Gurevich V, Fichtman B, Gavert N, Straussman R, Rechnitzer H, Barzilay M, Shvalb S, Bornstein J, Ben-Shachar I, Yagel S, Haviv I, Koren O.

BJOG. 2019 Aug 2. doi: 10.1111/1471-0528.15896. [Epub ahead of print]

PMID:
31376240
2.

Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.

Perez S, Kaspi A, Domovitz T, Davidovich A, Lavi-Itzkovitz A, Meirson T, Alison Holmes J, Dai CY, Huang CF, Chung RT, Nimer A, El-Osta A, Yaari G, Stemmer SM, Yu ML, Haviv I, Gal-Tanamy M.

PLoS Genet. 2019 Jun 19;15(6):e1008181. doi: 10.1371/journal.pgen.1008181. eCollection 2019 Jun.

3.

Dysregulation of the cohesin subunit RAD21 by Hepatitis C virus mediates host-virus interactions.

Perez S, Gevor M, Davidovich A, Kaspi A, Yamin K, Domovich T, Meirson T, Matityahu A, Brody Y, Stemmer SM, El-Osta A, Haviv I, Onn I, Gal-Tanamy M.

Nucleic Acids Res. 2019 Mar 18;47(5):2455-2471. doi: 10.1093/nar/gkz052.

4.

Can molecular profiling enhance radiotherapy? Impact of personalized targeted gold nanoparticles on radiosensitivity and imaging of adenoid cystic carcinoma.

Hazkani I, Motiei M, Betzer O, Sadan T, Bragilovski D, Lubimov L, Mizrachi A, Hadar T, Levi M, Ben-Aharon I, Haviv I, Popovtzer R, Popovtzer A.

Theranostics. 2017 Sep 14;7(16):3962-3971. doi: 10.7150/thno.19615. eCollection 2017.

5.

Interactions within the MHC contribute to the genetic architecture of celiac disease.

Goudey B, Abraham G, Kikianty E, Wang Q, Rawlinson D, Shi F, Haviv I, Stern L, Kowalczyk A, Inouye M.

PLoS One. 2017 Mar 10;12(3):e0172826. doi: 10.1371/journal.pone.0172826. eCollection 2017.

6.

Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density.

Chew GL, Huo CW, Huang D, Hill P, Cawson J, Frazer H, Hopper JL, Haviv I, Henderson MA, Britt K, Thompson EW.

Breast Cancer Res Treat. 2015 Aug;153(1):89-99. doi: 10.1007/s10549-015-3520-2. Epub 2015 Jul 31.

PMID:
26227474
7.

Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers.

Yan M, Shield-Artin K, Byrne D, Deb S, Waddell N; kConFab Investigators, kConFab, Haviv I, Fox SB.

BMC Cancer. 2015 Jul 8;15:506. doi: 10.1186/s12885-015-1522-4.

8.

Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.

Hong MK, Macintyre G, Wedge DC, Van Loo P, Patel K, Lunke S, Alexandrov LB, Sloggett C, Cmero M, Marass F, Tsui D, Mangiola S, Lonie A, Naeem H, Sapre N, Phal PM, Kurganovs N, Chin X, Kerger M, Warren AY, Neal D, Gnanapragasam V, Rosenfeld N, Pedersen JS, Ryan A, Haviv I, Costello AJ, Corcoran NM, Hovens CM.

Nat Commun. 2015 Apr 1;6:6605. doi: 10.1038/ncomms7605.

9.

Promoting Precision Cancer Medicine through a Community-Driven Knowledgebase.

Geifman N, Haviv I, Kurzrock R, Rubin E.

J Pers Med. 2014 Dec 15;4(4):475-88. doi: 10.3390/jpm4040475.

10.

A novel role for the Pol I transcription factor UBTF in maintaining genome stability through the regulation of highly transcribed Pol II genes.

Sanij E, Diesch J, Lesmana A, Poortinga G, Hein N, Lidgerwood G, Cameron DP, Ellul J, Goodall GJ, Wong LH, Dhillon AS, Hamdane N, Rothblum LI, Pearson RB, Haviv I, Moss T, Hannan RD.

Genome Res. 2015 Feb;25(2):201-12. doi: 10.1101/gr.176115.114. Epub 2014 Dec 1.

11.

Effects of Tamoxifen and oestrogen on histology and radiographic density in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers.

Chew GL, Huo CW, Huang D, Blick T, Hill P, Cawson J, Frazer H, Southey MC, Hopper JL, Britt K, Henderson MA, Haviv I, Thompson EW.

Breast Cancer Res Treat. 2014 Nov;148(2):303-14. doi: 10.1007/s10549-014-3169-2. Epub 2014 Oct 21.

PMID:
25332094
12.

Canonical androstenedione reduction is the predominant source of signaling androgens in hormone-refractory prostate cancer.

Fankhauser M, Tan Y, Macintyre G, Haviv I, Hong MK, Nguyen A, Pedersen JS, Costello AJ, Hovens CM, Corcoran NM.

Clin Cancer Res. 2014 Nov 1;20(21):5547-57. doi: 10.1158/1078-0432.CCR-13-3483. Epub 2014 Apr 25.

13.

Vascular histone deacetylation by pharmacological HDAC inhibition.

Rafehi H, Balcerczyk A, Lunke S, Kaspi A, Ziemann M, Kn H, Okabe J, Khurana I, Ooi J, Khan AW, Du XJ, Chang L, Haviv I, Keating ST, Karagiannis TC, El-Osta A.

Genome Res. 2014 Aug;24(8):1271-84. doi: 10.1101/gr.168781.113. Epub 2014 Apr 14.

14.

Widespread FRA1-dependent control of mesenchymal transdifferentiation programs in colorectal cancer cells.

Diesch J, Sanij E, Gilan O, Love C, Tran H, Fleming NI, Ellul J, Amalia M, Haviv I, Pearson RB, Tulchinsky E, Mariadason JM, Sieber OM, Hannan RD, Dhillon AS.

PLoS One. 2014 Mar 21;9(3):e88950. doi: 10.1371/journal.pone.0088950. eCollection 2014.

15.

A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal response.

Busuttil RA, George J, Tothill RW, Ioculano K, Kowalczyk A, Mitchell C, Lade S, Tan P, Haviv I, Boussioutas A.

Clin Cancer Res. 2014 May 15;20(10):2761-72. doi: 10.1158/1078-0432.CCR-13-3049. Epub 2014 Mar 21.

16.

BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.

Safra T, Lai WC, Borgato L, Nicoletto MO, Berman T, Reich E, Alvear M, Haviv I, Muggia FM.

Ann Oncol. 2013 Nov;24 Suppl 8:viii63-viii68. doi: 10.1093/annonc/mdt315.

PMID:
24131973
17.

Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes.

Meikle PJ, Wong G, Barlow CK, Weir JM, Greeve MA, MacIntosh GL, Almasy L, Comuzzie AG, Mahaney MC, Kowalczyk A, Haviv I, Grantham N, Magliano DJ, Jowett JB, Zimmet P, Curran JE, Blangero J, Shaw J.

PLoS One. 2013 Sep 27;8(9):e74341. doi: 10.1371/journal.pone.0074341. eCollection 2013.

18.

Dynamic changes in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers during various murine peripartum states and over time.

Chew GL, Huang D, Huo CW, Blick T, Hill P, Cawson J, Frazer H, Southey MD, Hopper JL, Henderson MA, Haviv I, Thompson EW.

Breast Cancer Res Treat. 2013 Jul;140(2):285-97. doi: 10.1007/s10549-013-2642-7. Epub 2013 Jul 24.

PMID:
23881524
19.

Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.

Choudhury S, Almendro V, Merino VF, Wu Z, Maruyama R, Su Y, Martins FC, Fackler MJ, Bessarabova M, Kowalczyk A, Conway T, Beresford-Smith B, Macintyre G, Cheng YK, Lopez-Bujanda Z, Kaspi A, Hu R, Robens J, Nikolskaya T, Haakensen VD, Schnitt SJ, Argani P, Ethington G, Panos L, Grant M, Clark J, Herlihy W, Lin SJ, Chew G, Thompson EW, Greene-Colozzi A, Richardson AL, Rosson GD, Pike M, Garber JE, Nikolsky Y, Blum JL, Au A, Hwang ES, Tamimi RM, Michor F, Haviv I, Liu XS, Sukumar S, Polyak K.

Cell Stem Cell. 2013 Jul 3;13(1):117-30. doi: 10.1016/j.stem.2013.05.004. Epub 2013 Jun 13.

20.

A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling.

Chen YC, Bui AV, Diesch J, Manasseh R, Hausding C, Rivera J, Haviv I, Agrotis A, Htun NM, Jowett J, Hagemeyer CE, Hannan RD, Bobik A, Peter K.

Circ Res. 2013 Jul 19;113(3):252-65. doi: 10.1161/CIRCRESAHA.113.301562. Epub 2013 Jun 7.

PMID:
23748430
21.

Determining epithelial contribution to in vivo mesenchymal tumour expression signature using species-specific microarray profiling analysis of xenografts.

Purdom E, Restall C, Busuttil RA, Schluter H, Boussioutas A, Thompson EW, Anderson RL, Speed TP, Haviv I.

Genet Res (Camb). 2013 Feb;95(1):14-29. doi: 10.1017/S0016672313000013. Epub 2013 Mar 18.

PMID:
23497823
22.

Discovery and analysis of consistent active sub-networks in cancers.

Gaire RK, Smith L, Humbert P, Bailey J, Stuckey PJ, Haviv I.

BMC Bioinformatics. 2013;14 Suppl 2:S7. doi: 10.1186/1471-2105-14-S2-S7. Epub 2013 Jan 21.

23.

High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers.

Chew GL, Huang D, Lin SJ, Huo C, Blick T, Henderson MA, Hill P, Cawson J, Morrison WA, Campbell IG, Hopper JL, Southey MC, Haviv I, Thompson EW.

Breast Cancer Res Treat. 2012 Aug;135(1):177-87. doi: 10.1007/s10549-012-2128-z. Epub 2012 Jun 23.

PMID:
22729891
24.

Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers.

Yan M, Xu H, Waddell N, Shield-Artin K, Haviv I; kConFab authors, McKay MJ, Fox SB.

Breast Cancer Res. 2012 Apr 26;14(2):R69.

25.

Soiling the seed: microenvironment and epithelial mesenchymal plasticity.

Haviv I, Thompson EW.

Cancer Microenviron. 2012 Apr;5(1):1-3. doi: 10.1007/s12307-012-0104-0. No abstract available.

26.

Vascular normalization by loss of Siah2 results in increased chemotherapeutic efficacy.

Wong CS, Sceneay J, House CM, Halse HM, Liu MC, George J, Hunnam TC, Parker BS, Haviv I, Ronai Z, Cullinane C, Bowtell DD, Möller A.

Cancer Res. 2012 Apr 1;72(7):1694-704. doi: 10.1158/0008-5472.CAN-11-3310. Epub 2012 Feb 21.

27.

Plasma lipidomic analysis of stable and unstable coronary artery disease.

Meikle PJ, Wong G, Tsorotes D, Barlow CK, Weir JM, Christopher MJ, MacIntosh GL, Goudey B, Stern L, Kowalczyk A, Haviv I, White AJ, Dart AM, Duffy SJ, Jennings GL, Kingwell BA.

Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2723-32. doi: 10.1161/ATVBAHA.111.234096.

PMID:
21903946
28.

The social aspects of EMT-MET plasticity.

Thompson EW, Haviv I.

Nat Med. 2011 Sep 7;17(9):1048-9. doi: 10.1038/nm.2437. No abstract available.

PMID:
21900919
29.

Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells.

Pirola L, Balcerczyk A, Tothill RW, Haviv I, Kaspi A, Lunke S, Ziemann M, Karagiannis T, Tonna S, Kowalczyk A, Beresford-Smith B, Macintyre G, Kelong M, Hongyu Z, Zhu J, El-Osta A.

Genome Res. 2011 Oct;21(10):1601-15. doi: 10.1101/gr.116095.110. Epub 2011 Sep 2.

30.

Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expression.

Ahrens I, Domeij H, Topcic D, Haviv I, Merivirta RM, Agrotis A, Leitner E, Jowett JB, Bode C, Lappas M, Peter K.

PLoS One. 2011;6(8):e23210. doi: 10.1371/journal.pone.0023210. Epub 2011 Aug 12.

31.

Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells.

Ahrens I, Domeij H, Eisenhardt SU, Topcic D, Albrecht M, Leitner E, Viitaniemi K, Jowett JB, Lappas M, Bode C, Haviv I, Peter K.

Basic Res Cardiol. 2011 Sep;106(5):879-95. doi: 10.1007/s00395-011-0191-y. Epub 2011 May 12.

32.

Epigenetic regulation of cell type-specific expression patterns in the human mammary epithelium.

Maruyama R, Choudhury S, Kowalczyk A, Bessarabova M, Beresford-Smith B, Conway T, Kaspi A, Wu Z, Nikolskaya T, Merino VF, Lo PK, Liu XS, Nikolsky Y, Sukumar S, Haviv I, Polyak K.

PLoS Genet. 2011 Apr;7(4):e1001369. doi: 10.1371/journal.pgen.1001369. Epub 2011 Apr 21.

33.

Meta-analysis of gene expression microarrays with missing replicates.

Shi F, Abraham G, Leckie C, Haviv I, Kowalczyk A.

BMC Bioinformatics. 2011 Mar 24;12:84. doi: 10.1186/1471-2105-12-84.

34.

Appraisal of progenitor markers in the context of molecular classification of breast cancers.

Haviv I.

Breast Cancer Res. 2011 Jan 25;13(1):102. doi: 10.1186/bcr2792.

35.

Genetic changes in tumour microenvironments.

Campbell I, Qiu W, Haviv I.

J Pathol. 2011 Mar;223(4):450-8. doi: 10.1002/path.2842. Epub 2011 Jan 17. Review.

PMID:
21294119
36.

Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue.

Lin SJ, Cawson J, Hill P, Haviv I, Jenkins M, Hopper JL, Southey MC, Campbell IG, Thompson EW.

Breast Cancer Res Treat. 2011 Jul;128(2):505-16. doi: 10.1007/s10549-011-1346-0. Epub 2011 Jan 22.

PMID:
21258862
37.

Combining target enrichment with barcode multiplexing for high throughput SNP discovery.

Cummings N, King R, Rickers A, Kaspi A, Lunke S, Haviv I, Jowett JB.

BMC Genomics. 2010 Nov 18;11:641. doi: 10.1186/1471-2164-11-641.

38.

A bi-ordering approach to linking gene expression with clinical annotations in gastric cancer.

Shi F, Leckie C, MacIntyre G, Haviv I, Boussioutas A, Kowalczyk A.

BMC Bioinformatics. 2010 Sep 23;11:477. doi: 10.1186/1471-2105-11-477.

39.

is-rSNP: a novel technique for in silico regulatory SNP detection.

Macintyre G, Bailey J, Haviv I, Kowalczyk A.

Bioinformatics. 2010 Sep 15;26(18):i524-30. doi: 10.1093/bioinformatics/btq378.

40.

Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".

Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, Ness RB, Moysich KB, Chang-Claude J, Wang-Gohrke S, Cramer DW, Terry KL, Hankinson SE, Tworoger SS, Garcia-Closas M, Yang H, Lissowska J, Chanock SJ, Pharoah PD, Song H, Whitemore AS, Pearce CL, Stram DO, Wu AH, Pike MC, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Anton-Culver H, Ziogas A, Hogdall E, Kjaer SK, Hogdall C, Berchuck A, Schildkraut JM, Iversen ES, Moorman PG, Phelan CM, Sellers TA, Cunningham JM, Vierkant RA, Rider DN, Goode EL, Haviv I, Chenevix-Trench G; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group; Australian Cancer Study (Ovarian Cancer).

PLoS Genet. 2010 Jul 8;6(7):e1001016. doi: 10.1371/journal.pgen.1001016.

41.

Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context.

Abraham G, Kowalczyk A, Loi S, Haviv I, Zobel J.

BMC Bioinformatics. 2010 May 25;11:277. doi: 10.1186/1471-2105-11-277.

42.

Exploiting sequence similarity to validate the sensitivity of SNP arrays in detecting fine-scaled copy number variations.

Wong G, Leckie C, Gorringe KL, Haviv I, Campbell IG, Kowalczyk A.

Bioinformatics. 2010 Apr 15;26(8):1007-14. doi: 10.1093/bioinformatics/btq088. Epub 2010 Feb 25.

PMID:
20189937
43.

EBNA1 regulates cellular gene expression by binding cellular promoters.

Canaan A, Haviv I, Urban AE, Schulz VP, Hartman S, Zhang Z, Palejev D, Deisseroth AB, Lacy J, Snyder M, Gerstein M, Weissman SM.

Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22421-6. doi: 10.1073/pnas.0911676106. Epub 2009 Dec 22.

44.

MIRAGAA--a methodology for finding coordinated effects of microRNA expression changes and genome aberrations in cancer.

Gaire RK, Bailey J, Bearfoot J, Campbell IG, Stuckey PJ, Haviv I.

Bioinformatics. 2010 Jan 15;26(2):161-7. doi: 10.1093/bioinformatics/btp654. Epub 2009 Nov 23.

PMID:
19933823
45.

Clonal mutations in the cancer-associated fibroblasts: the case against genetic coevolution.

Campbell I, Polyak K, Haviv I.

Cancer Res. 2009 Sep 1;69(17):6765-8; discussion 6769. doi: 10.1158/0008-5472.CAN-08-4253. Epub 2009 Aug 25. Erratum in: Cancer Res. 2009 Oct 1;69(19):7894.

46.

Origin of carcinoma associated fibroblasts.

Haviv I, Polyak K, Qiu W, Hu M, Campbell I.

Cell Cycle. 2009 Feb 15;8(4):589-95. Epub 2009 Feb 19. Review.

PMID:
19182519
47.

Co-evolution of tumor cells and their microenvironment.

Polyak K, Haviv I, Campbell IG.

Trends Genet. 2009 Jan;25(1):30-8. doi: 10.1016/j.tig.2008.10.012. Epub 2008 Dec 4. Review.

PMID:
19054589
48.

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.

Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro B, Traficante N, Fereday S, Hung JA, Chiew YE, Haviv I; Australian Ovarian Cancer Study Group, Gertig D, DeFazio A, Bowtell DD.

Clin Cancer Res. 2008 Aug 15;14(16):5198-208. doi: 10.1158/1078-0432.CCR-08-0196.

49.

No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas.

Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, Trivett M, Thompson ER, Ramakrishna M, Gorringe KL, Polyak K, Haviv I, Campbell IG.

Nat Genet. 2008 May;40(5):650-5. doi: 10.1038/ng.117. Epub 2008 Apr 13.

50.

Breast-cancer stromal cells with TP53 mutations.

Campbell IG, Qiu W, Polyak K, Haviv I.

N Engl J Med. 2008 Apr 10;358(15):1634-5; author reply 1636. doi: 10.1056/NEJMc086024. No abstract available.

PMID:
18403774

Supplemental Content

Support Center